Fidelity Investments’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $804K | Buy |
19,850
+915
| +5% | +$37.1K | ﹤0.01% | 2795 |
|
|
2025
Q1 | $973K | Sell |
18,935
-14,892
| -44% | -$765K | ﹤0.01% | 2687 |
|
|
2024
Q4 | $1.87M | Buy |
33,827
+28,795
| +572% | +$1.59M | ﹤0.01% | 2464 |
|
|
2024
Q3 | $166K | Buy |
5,032
+3,537
| +237% | +$116K | ﹤0.01% | 3261 |
|
|
2024
Q2 | $40.6K | Sell |
1,495
-264
| -15% | -$7.18K | ﹤0.01% | 3714 |
|
|
2024
Q1 | $63.9K | Buy |
1,759
+142
| +9% | +$5.16K | ﹤0.01% | 3461 |
|
|
2023
Q4 | $32.7K | Buy |
1,617
+513
| +46% | +$10.4K | ﹤0.01% | 3719 |
|
|
2023
Q3 | $19.6K | Buy |
1,104
+279
| +34% | +$4.96K | ﹤0.01% | 3812 |
|
|
2023
Q2 | $14.9K | Sell |
825
-301
| -27% | -$5.44K | ﹤0.01% | 3991 |
|
|
2023
Q1 | $14.2K | Buy |
1,126
+978
| +661% | +$12.3K | ﹤0.01% | 3991 |
|
|
2022
Q4 | $2.17K | Sell |
148
-249
| -63% | -$3.65K | ﹤0.01% | 4491 |
|
|
2022
Q3 | $7K | Buy |
397
+269
| +210% | +$4.74K | ﹤0.01% | 4214 |
|
|
2022
Q2 | $2K | Buy |
128
+84
| +191% | +$1.31K | ﹤0.01% | 4603 |
|
|
2022
Q1 | $1K | Buy |
+44
| New | +$1K | ﹤0.01% | 4847 |
|